Shafer Christina
- SEC CIK
- 0001934412
No open-market purchases or sales filed in the past year.
Current role at each company
- NGNE Neurogene Inc.Chief Commercial Officeras of May 7, 2026
- MRNS Marinus Pharmaceuticals, Inc.CHIEF COMMERCIAL OFFICERas of Feb 11, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Shafer Christina as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MRNS Marinus Pharmaceuticals, Inc.
CHIEF COMMERCIAL OFFICER3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2024 (view filing) | Aug 5 | 2 days | Shafer ChristinaCHIEF COMMERCIAL OFFICER | SSale | −3.82K | $1.14 | −$4.35K | −5.4%67.4K after | |
| Feb 22, 2024 (view filing) | Feb 20 | 2 days | Shafer ChristinaCHIEF COMMERCIAL OFFICER | SSale | −2.15K | $9.56 | −$20.6K | −3.4%60.3K after | |
| Aug 8, 2023 (view filing) | Aug 7-8 | 1 day | Shafer ChristinaCHIEF COMMERCIAL OFFICER | SSale | −2.40K | $9.52 | −$22.8K | −5.6%40.6K after | 2 lots10b5-1 |